Clinical Trial Update: VX-950-TiDP24-C124: A Phase I Trial to Investigate the Potential Pharmacokinetic Interactions Between Telaprevir and Darunavir/Ritonavir and Between Telaprevir and Fosamprenavir/Ritonavir at Steady-state. [Phase 1]

View source ↗

Summary

Phase I study evaluating potential pharmacokinetic interactions between telaprevir and HIV protease inhibitors (darunavir/ritonavir and fosamprenavir/ritonavir)…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis C

Drugs mentioned

• Fosamprenavir/ritonavir (fosamprenavir/ritonavir)
• Telaprevir (telaprevir)
• darunavir/ritonavir (darunavir/ritonavir)

Snippet

Sponsor: Tibotec BVBA | Conditions: Hepatitis C, Telaprevir | Phase 1 | Status: COMPLETED